What Is IVZ Fair Value?
Invesco (IVZ) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Invesco (IVZ) has a composite fair value estimate of $74.74 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $28.92, suggesting the stock is undervalued by 158.4%.
Data as of October 14, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$74.74
vs. current price of $28.92(+158.4%)
How Is IVZ Fair Value Calculated?
Four independent models estimate what IVZ is worth. Each uses different inputs and assumptions. The composite blends them by weight.
IVZ Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$105.75
+265.7%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$16.98
-41.3%Overvalued
Inputs used
IVZ Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$37.75
+30.5%Undervalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$76.86
+165.8%Undervalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $28.92 is 265.7% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.43B | $1.27B |
| Year 2 | $1.78B | $1.41B |
| Year 3 | $2.23B | $1.57B |
| Year 4 | $2.79B | $1.75B |
| Year 5 | $3.48B | $1.94B |
| Year 6 | $4.35B | $2.16B |
| Year 7 | $5.44B | $2.40B |
| Year 8 | $6.80B | $2.67B |
| Year 9 | $8.50B | $2.97B |
| Year 10 | $10.62B | $3.30B |
| Terminal Value | $110.04B | $34.20B |
What Are IVZ's Key Financial Metrics?
Earnings & Growth
Current Price
$28.92
EPS (TTM)
-$0.68
Forward P/E
8.8
Profit Margin
-0.9%
Cash & Balance Sheet
Free Cash Flow
1.1B
EBITDA
1.4B
Book Value
$22.56
Total Debt
1.6B
What Do Analysts Say About IVZ?
Low
$30.00
Average
$34.86
High
$41.00
Upside
+20.5%
IVZ Fair Value FAQ
What is the fair value of IVZ?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), IVZ's estimated fair value is $74.74. The stock is currently trading at $28.92, which makes it undervalued by our analysis.
How is IVZ's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is IVZ overvalued or undervalued?
Based on our analysis, IVZ is undervalued. The current price of $28.92 is 158.4% below our estimated fair value of $74.74.
What do Wall Street analysts say about IVZ?
14 analysts cover Invesco with a consensus rating of "Buy." The average price target is $34.86, ranging from $30.00 to $41.00. This implies 20.5% upside from the current price.